Background
Methods
Statistical analysis
Results
Men | Women | |||||
---|---|---|---|---|---|---|
No BMI change | BMI decrease | BMI increase | No BMI change | BMI decrease | BMI increase | |
N
| 4162 (65.7%) | 1489 (23.5%) | 685 (10.8%) | 4651 (63.8%) | 1634 (22.4%) | 1010 (13.8%) |
Age | 58.65 ± 11.85 | 58.25 ± 11.70 | 58.53 ± 11.87 | 63.57 ± 11.57 | 63.41 ± 11.02 | 36.36 ± 11.09 |
BMI | 29.73 ± 3.89 | 30.17 ± 4.32 | 29.98 ± 4.95 | 29.11 ± 4.73 | 30.38 ± 4.71 | 29.78 ± 5.10 |
SBP (mmHg) | 140.45 ± 15.99 | 140.51 ± 17.35 | 140.02 ± 16.57 | 140.50 ± 16.16 | 140.98 ± 17.42* | 140.35 ± 16.21 |
SBP at 12 months (mmHg) | 132.94 ± 10.48* | 131.06 ± 9.72* | 134.41 ± 11.58* | 131.21 ± 9.70* | 130.21 ± 10.48* | 132.36 ± 11.49* |
DBP (mmHg) | 85.21 ± 8.74* | 85.02 ± 9.88* | 84.75 ± 7.94* | 84.89 ± 9.74* | 84.93 ± 9.81 | 83.75 ± 9.79* |
DBP at 12 months (mmHg) | 80.43 ± 6.81* | 80.25 ± 6.9* | 82,19 ± 7,0* | 79.59 ± 6.8* | 78.83 ± 6.7* | 80.55 ± 8.0* |
Creatinine (μmol/l) | 82.63 ± 18.90 | 81.78 ± 18.42 | 82.53 ± 18.09 | 81.78 ± 17.96 | 82.83 ± 19.37 | 80.23 ± 17.58 |
Minimal effective doses of medication | 3.89 ± 2.28 | 4.09 ± 2.35 | 4.04. ± 2.54 | 3.36 ± 2.28 | 3.89 ± 2.26 | 4.03 ± 2.43 |
Diabetes mellitus (%) | 14.8 | 15.0 | 14.9 | 12.7 | 12.9 | 12.4 |
Controlled hypertension (%) | 42.27 | 38.88 | 42.62 | 43.44 | 42.90 | 42.62 |
Smoking (%) | 32.40 | 31.30 | 31.42 | 15.39 | 15.46 | 15.24 |
Anamnesis of stroke (%) | 6.19 | 6.28 | 6.79 | 5.41 | 5.25 | 5.38 |
Anamnesis of MI (%) | 10.88 | 10.73 | 10.62 | 5.50 | 5.01 | 5.78 |
BB (%) | 31.83 | 29.50 | 29.93 | 35.10 | 34.13 | 32.80 |
ACEI/sartans (%) | 89.83 | 90.42 | 89.70 | 92.03 | 93.00 | 91.72 |
Diuretics (%) | 39.86 | 37.96 | 40.86 | 40.78 | 40.66 | 41.90 |
CCB (%) | 35.69 | 37.75 | 34.10 | 34.37 | 33.25 | 34.21 |
CAH (%) | 10.55 | 9.56 | 10.94 | 12.78 | 11.83 | 11.57 |
BMI at the baseline |
N
| Uncontrolled (%) | OR | 95% CI |
p
|
---|---|---|---|---|---|
Men BMI 25–29.9 | 3029 | 56.1 | 1.174 | 1.016–1.356 | < 0.0001 |
Men BMI ≥ 30 | 2423 | 61.4 | 1.461 | 1.262–1.690 | < 0.0001 |
Women BMI 25–29.9 | 2988 | 56.0 | 1.076 | 0.9402–1.231 | 0.288 |
Women BMI ≥ 30 | 3095 | 60.9 | 1.321 | 1.151–1.515 | < 0.0001 |
BMI decrease and hypertension control
BMI at the baseline | Gender |
p
| OR | 95% CI |
---|---|---|---|---|
BMI < 25 | Men | 0.397 | 0.771 | 0.423–1.406 |
Women | 0.242 | 0.743 | 0.451–1.223 | |
BMI 25–29.9 | Men | < 0.05 | 0.804 | 0.636–0.997 |
Women | < 0.05 | 0.732 | 0.568–0.937 | |
BMI ≥ 30 | Men | < 0.0001 | 0.586 | 0.481–0.713 |
Women | < 0.001 | 0.730 | 0.611–0.876 |
BMI increase and hypertension control
BMI at the baseline | Gender |
p
| OR | 95% CI |
---|---|---|---|---|
BMI < 25 | Men | 0.131 | 1.383 | 0. 908–2.104 |
Women | 0.247 | 1.166 | 0.846–1.607 | |
BMI 25–29.9 | Men | < 0.0001 | 1.901 | 1.463–2.470 |
Women | < 0.0001 | 1.647 | 1.304–2.080 | |
BMI ≥ 30 | Men | < 0.001 | 1.471 | 1.087–1.991 |
Women | < 0.001 | 1.422 | 1.104–1.833 |